CAS 1513879-21-4

BQR-695

CAS: 1513879-21-4

Fórmula: C₁₉H₂₀N₄O₃

Pureza: 99%

Forma y color: Solid

Peso molecular: 352.3871

Ref: IN-DA01EO94

2-((7-(3,4-Dimethoxyphenyl)Quinoxalin-2-Yl)Amino)-N-Methylacetamide

CAS: 1513879-21-4

2-((7-(3,4-Dimethoxyphenyl)Quinoxalin-2-Yl)Amino)-N-Methylacetamide

Pureza: 99%

Peso molecular: 352.39g/mol

Ref: 54-OR1026334

BQR-695

CAS: 1513879-21-4

BQR-695

Pureza: ≥95%

Peso molecular: 352.39g/mol

Ref: 54-BUP10211

BQR-695

CAS: 1513879-21-4

BQR-695 (NVP-BQR695) is a PI4K inhibitor with IC50s of 80 and 3.5 nM for human PI4KIIIβ and Plasmodium variant of PI4KIIIβ, respectively.

Fórmula: C₁₉H₂₀N₄O₃

Pureza: 98.91% - 99.69%

Forma y color: Solid

Peso molecular: 352.39

Ref: TM-T4220

2-((7-(3,4-Dimethoxyphenyl)quinoxalin-2-yl)amino)-N-methylacetamide

CAS: 1513879-21-4

Pureza: 99%

Peso molecular: 352.3940125

Ref: 10-F867297

BQR 695

CAS: 1513879-21-4

BQR 695 is a small molecule drug candidate that inhibits the production of DNA and RNA by binding to the viral enzyme, reverse transcriptase. BQR 695 has been shown to have a high degree of selectivity for cancer cells with little or no activity against normal cells. It has also been shown to act as an immunosuppressant by inhibiting T cell activation in mice. The molecular mechanism of this drug is not well understood but it is thought that BQR 695 interacts with the cellular protein, bcl-2, which regulates apoptosis.

Fórmula: C₁₉H₂₀N₄O₃

Pureza: Min. 95%

Peso molecular: 352.39 g/mol

Ref: 3D-NKC87921